Literature DB >> 18675893

Theoretical comparison of hydrodynamic diffusion layer models used for dissolution simulation in drug discovery and development.

Kiyohiko Sugano1.   

Abstract

The effective hydrodynamic diffusion layer thickness (h(eff)) of a drug particle dissolving into an agitated fluid is of great importance for oral absorption simulation. The purpose of the present study was to: (1) introduce a h(eff) estimation method based on the fluid dynamic theory (FD model), and (2) compare the FD model with the non-FD-based approximation models previously reported by Hintz and Johnson (HJ model) and Wang and Flanagan (WF model). In the FD model, the relative velocity of a particle suspended in an agitated fluid was estimated from the terminal slip velocity and the microeddy effect. For small particles (particle radius (r(p))<ca. 15microm), the HJ, WF and FD models resulted in the similar h(eff) values, whereas they resulted in different h(eff) values for large particles (r(p)>ca. 15microm). One of the merits of the FD model is that it provides the a priori theoretical estimation of h(eff) from particle radius, drug density, agitation strength, fluid viscosity, and diffusion coefficient. The hydrodynamic conditions in the gastrointestinal (GI) tract differ among human and animals, the GI sites, and fasted/fed conditions, etc. Therefore, the FD model could provide a more comprehensive and sophisticated simulation of oral absorption.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18675893     DOI: 10.1016/j.ijpharm.2008.07.002

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  8 in total

1.  Variance based global sensitivity analysis of physiologically based pharmacokinetic absorption models for BCS I-IV drugs.

Authors:  Nicola Melillo; Leon Aarons; Paolo Magni; Adam S Darwich
Journal:  J Pharmacokinet Pharmacodyn       Date:  2018-12-14       Impact factor: 2.745

2.  Dissolution studies of poorly soluble drug nanosuspensions in non-sink conditions.

Authors:  Peng Liu; Odile De Wulf; Johanna Laru; Teemu Heikkilä; Bert van Veen; Juha Kiesvaara; Jouni Hirvonen; Leena Peltonen; Timo Laaksonen
Journal:  AAPS PharmSciTech       Date:  2013-04-25       Impact factor: 3.246

3.  Dissolution testing of powders for inhalation: influence of particle deposition and modeling of dissolution profiles.

Authors:  Sabine May; Birte Jensen; Claudius Weiler; Markus Wolkenhauer; Marc Schneider; Claus-Michael Lehr
Journal:  Pharm Res       Date:  2014-05-23       Impact factor: 4.200

Review 4.  Lipid-associated oral delivery: Mechanisms and analysis of oral absorption enhancement.

Authors:  Oljora Rezhdo; Lauren Speciner; Rebecca Carrier
Journal:  J Control Release       Date:  2016-08-09       Impact factor: 9.776

5.  Development of a Novel Simplified PBPK Absorption Model to Explain the Higher Relative Bioavailability of the OROS® Formulation of Oxybutynin.

Authors:  Andrés Olivares-Morales; Avijit Ghosh; Leon Aarons; Amin Rostami-Hodjegan
Journal:  AAPS J       Date:  2016-09-08       Impact factor: 4.009

6.  Lost in modelling and simulation?

Authors:  Kiyohiko Sugano
Journal:  ADMET DMPK       Date:  2021-03-22

7.  Characterization of Membrane-Type Dissolution Profiles of Clinically Available Orally Inhaled Products Using a Weibull Fit and a Mechanistic Model.

Authors:  Irès van der Zwaan; Frans Franek; Rebecca Fransson; Ulrika Tehler; Göran Frenning
Journal:  Mol Pharm       Date:  2022-08-08       Impact factor: 5.364

8.  Model for the Analysis of Membrane-Type Dissolution Tests for Inhaled Drugs.

Authors:  Göran Frenning; Irès van der Zwaan; Frans Franek; Rebecca Fransson; Ulrika Tehler
Journal:  Mol Pharm       Date:  2020-06-15       Impact factor: 4.939

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.